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Abstract
Background: Gastrointestinal nematode (GIN) infections are the predominant cause of economic losses in sheep.
Infections are controlled almost exclusively by the use of anthelmintics which has lead to the selection of drug
resistant nematode strains. An alternative control approach would be the induction of protective immunity to
these parasites. This study exploits an ovine microarray biased towards immune genes, an artificially induced
immunity model and the use of pseudo-afferent lymphatic cannulation to sample immune cells draining from the
intestine, to investigate possible mechanisms involved in the development of immunity.
Results: During the development of immunity to, and a subsequent challenge infection with Trichostrongylus
colubriformis, the transcript levels of 2603 genes of cells trafficking in afferent intestinal lymph were significantly
modulated (P < 0.05). Of these, 188 genes were modulated more than 1.3-fold and involved in immune function.
Overall, there was a clear trend for down-regulation of many genes involved in immune functions including
antigen presentation, caveolar-mediated endocytosis and protein ubiquitination. The transcript levels of TNF
receptor associated factor 5 (TRAF5), hemopexin (HPX), cysteine dioxygenase (CDO1), the major histocompatability
complex Class II protein (HLA-DMA), interleukin-18 binding protein (IL-18BP), ephrin A1 (EFNA1) and selenoprotein
S (SELS) were modulated to the greatest degree.
Conclusions: This report describes gene expression profiles of afferent lymph cells in sheep developing immunity
to nematode infection. Results presented show a global down-regulation of the expression of immune genes
which may be reflective of the natural temporal response to nematode infections in livestock.
Background
In sheep, infections with gastrointestinal nematodes are
the most important individual cause of economic losses.
At present, control of nematode infections is dependent
on the repeated use of anthelmintics, but this constant
use of drugs has enabled strong selection for drug-resis-
tant nematode strains. Resistance to one or more of the
major anthelmintic drug families is common in all
major sheep producing countries, putting the economic
survival of sheep production at risk [1,2].
Generating high levels of protective immunity would
provide an alternative control option. A degree of
immunity does develop after repeated natural infections
acquired during grazing and this may be adequate to
enable the host to reject incoming larvae and to elimi-
nate existing infections. Effective immunity can also be
induced artificially by repeated infection with unnatu-
rally large numbers of gastrointestinal nematodes. For
example, repeated experimental infection with L3 larvae,
followed by drug treatment at a later stage of parasite
development, is recognized as an effective inducer of
protective immunity [3,4]. In general, the development
of protective immunity to nematode infection is marked
by a Th2-type cytokine response. In sheep and cattle IL-
13 and to some extent IL-5, are regarded as having
major roles in the induction of immunity to intestinal
nematode infections [5-7].
Analysis of global changes in gene expression using
microarray technology may aid the investigation of
immune responses of sheep to gastrointestinal parasites.
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This technology has already become an important tool
to examine complex biological processes in sheep com-
plementing the extensive body of knowledge that exists
for rodent and human disease models. Studies in sheep
include gene expression profiling of tissues relevant
to nematode infection in selection lines genetically resis-
tant or susceptible to GIN [8-12], in breeds with
natural resistance to GIN [13,14] and in non-selection
lines [11,15].
The investigation of changes of gene expression pro-
files in the immune cells that migrate out of the intest-
inal environment would help to dissect the specific and
essential role that these cells play in the development
and dissemination of immunity to GIN. A pseudo-affer-
ent lymphatic cannulation procedure was used in this
study to enable access to large numbers of antigen pre-
senting cells (APC), in particular dendritic cells (DC), as
they migrate out of the intestinal environment. Recently,
we described and validated procedures to cannulate
pseudo-afferent lymphatic vessels in sheep and thereby
gain access to large numbers of afferent lymph cells
[16]. We also demonstrated differential expression in
these cells of specific cytokine genes relevant to nema-
tode immunity in selection line sheep [5]. This present
study has expanded this earlier work by performing a
genome wide screen for gene expression changes in
afferent lymph cells. This global examination of the
transcriptional activity of this key migrating cell popula-
tion extends the knowledge derived from immune tissue
studies [10,11,13]. Our results show that nematodes
down-regulate the expression of an unexpectedly high
proportion of immune genes in host cells migrating
from local tissue environments and that this is likely to
contribute to the slow development of natural immunity
to nematodes. Better insights into these modulated
genes and pathways should aid in identifying mechan-
isms linked to immune suppression and lead to the dis-
covery of novel immunomodulants.
Results
Validation of sample pooling strategy and microarray
data
For this study, we used pseudo-afferent lymphatic can-
nulation procedures to continuously access immune
cells migrating in lymph, draining directly from the
mucosa of the sheep small intestine. The long-term col-
lection of afferent lymph after cannulation has pre-
viously been extensively validated for sheep with GIN
infections [16]. The cell population in afferent intestinal
lymph contains approximately 15% DC and 85% lym-
phocytes. RNA from samples collected over one week,
from all experimental animals in each group, was
pooled. As expected, a classical Th2 cytokine profile
with up-regulation of IL-5, IL-13 and to a lesser extent
of IL-4, but with no changes in IFNg transcript levels,
was observed in these pooled samples with expression
levels peaking after the third immunising infection and
immediately after challenge (Figure 1). This is evidence
that pooling RNA within treatment groups over a 7 day
period did not obscure gene expression profiles shown
previously to be relevant to nematode immunity.
To confirm the microarray data, the levels of 7 ran-
domly selected genes in the sample pools were
assessed by qRT-PCR. The genes assessed were
CXCR3 and GNLY, identified during the repeated
immunising infections, and TRAF3, TLR6, SLA,
LOC509457 and a novel ovine gene identified during
parasite challenge. These data showed similar changes
over time between transcript levels assessed by qRT-
PCR or by the microarray (Figure 2) demonstrating the
validity of expression profile analysis using microarray
technology. In some instances a number of different
ESTs mapping to the same human or bovine gene
were spotted onto the microarray. In the majority of
cases the changes observed were similar for all ESTs
(for example HSP90AA1, 6 ESTs; HSPA8, 6 ESTs;
HLA-DQB1, 2 ESTs; YARS, 2 ESTs; ATP2B4, 2 ESTs;
CD151, 2 ESTs; CD47, 2 ESTs; ACTG2, 2 ESTs; see






















Figure 1 Analysis of transcript levels of Th2 effector cytokines.
The level of IL-4 (open triangle), IL-5 (black square), IL-13 (black
triangle) and IFNg (black circle) transcripts in sample pools were
measured by qRT-PCR. Expression levels were normalised to PI level.
PI = week 0, I1 = week 1, I2 = week 4, I3 = week 7, C1 = week 10,
C2 = week 11, C3 = week 12.
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Figure 2 qRT-PCR validation of microarray data. (A) CXCR3, chemokine (C-X-C) receptor 3; (B) GNLY, granulysin; (C) TRAF3, TNF receptor-
associated factor 3; (D) TLR6, toll-like receptor 6; (E) SLA, src-like-adaptor; (F) Novel Gene, no RefSeq; (G) LOC509457, predicted WD repeat
domain 73. Gene expression assessed by qRT-PCR (black triangle) is expressed relative to the PI level. A time course of microarray data (black
square) was calculated from comparative values and is expressed relative to the PI level. Comparative values used for this calculation are
tabulated. aDifferential expression of genes in pooled samples PI_I1, PI_I2, PI_I3, I1_I2, I1_I3, I2_I3 or PI_C1, PI_C2, PI_C3, C1_C2, C1_C3, C2_C3
where treated as described in Methods. Down regulated genes with more than a 1.3-fold decrease (-1.3) and a P value < 0.05 are highlighted
green. Up-regulated genes with > 1.3-fold increase and a P value < 0.05 are highlighted red. Genes where the change is less than a 1.3-fold
decrease or increase and with a P value < 0.05 are highlighted grey. The procedure and reagents used are described in Methods.
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Analysis of modulated genes
Filters were applied, and further analysis was carried out
on genes with statistically significant (P < 0.05) changes
in expression levels in at least one comparison. In total,
2603 unique ESTs were modulated during the immunis-
ing infections, or the subsequent challenge. This list
included 188 genes, modulated more than 1.3-fold (up
or down), involved in immune function.
During the development of immunity to T. colubrifor-
mis the levels of 2213 ESTs with either a bovine or
human homologue were statistically significantly (P <
0.05) modulated. During challenge this number was
1066 (Table 1). Of these 549 and 373 ESTs were modu-
lated more than 1.3-fold (up or down) in at least one
comparison during respectively the immunising or chal-
lenge infections. The greatest number of ESTs were
modulated when Immunising infection 1 was compared
to Immunising infection 2 (1353; I1_I2), and when the
Pre-infection sample was compared to either Challenge
infection week 2 (430; PI_C2) or to Challenge infection
week 3 (498; PI_C3; Table 1). Changes in gene expres-
sion levels were modest with maximally a 1.9-fold
increase and 2.6-fold decrease during the immunising
infections and a 3-fold increase and 3.4-fold decrease
during the challenge infection. Analysis of all ESTs
modulated more than 1.3-fold showed that many more
were down regulated than up regulated (Table 1).
Modulation of gene expression during repeated
truncated immunising infections
One hundred and two significantly regulated individual
ovine ESTs mapping to 98 different Human or Bovine
Reference genes, associated with immune function, were
modulated during the immunising infections. These
genes were predominantly represented in the functional
groupings of inflammatory response, immune cell traf-
ficking, antigen presentation, cellular movement, mam-
malian immunological disorder, cell-mediated immune
response, humoral immune response and infection
mechanism (Ingenuity Pathways Analysis, P < 0.02).
Repeated immunising infections resulted in the down-
regulation of the majority of immune genes (82 out of
102 ESTs, Additional file 1). The most consistently (sig-
nificant modulation in more than one comparison) and
strongly down-regulated genes were TNF receptor asso-
ciated factor 5 (TRAF5, 4/6 comparisons; -2.5 fold in
I1_I3), cysteine dioxygenase (CDO1, 2/6 comparisons;
-2.22-fold in I1_I2), hemopexin (HPX, 3/6 comparisons;
-2.01-fold in PI_I3) and the major histocompatability
complex Class II DM protein (HLA-DMA, 4/6 compari-
sons; -1.94- fold in PI_I3). For all four genes, the maxi-
mal decrease in transcript levels occurred by the first
week of the second immunising infection. The most
highly up-regulated genes were the interleukin-18 bind-
ing protein at the first week of the third Immunising
infection (IL18BP, 1/6 comparisons; 1.62-fold in PI_I3)
and ephrin-A1 (EFNA1, 2/6 comparisons; 1.56-fold in
PI_I3, Additional file 1). There was some additional
down-regulation of TRAF5 expression during the chal-
lenge infection (PI_I3, -2.43 compared to PI_C3, -3.41)
but for the other genes, maximum down-regulation had
occurred by the third immunising infection. The up-
regulated genes EFNA1 and IL18BP were not signifi-
cantly modulated in the challenge infection data set.
The canonical pathways (Acute Phase Response sig-
nalling, P = 2.9 × 10-6; Caveolar-mediated Endocytosis,
P = 1.61 × 10-5; Antigen Presentation, P = 8.05 × 10-5;
Ubiquination-Proteosome System, P = 1.59 × 10-3; IL-4
Table 1 Numbers of ESTs significantly modulated during immunising and challenge infections (P < 0.05)
Immunising Infection
Unique ESTs Comparisona
PI_I1 PI_I2 PI_I3 I1_I2 I1_I3 I2_I3
ESTs with RefSeq 2213 269 743 718 1353 650 193
Modulated more than 1.3-fold (up or down) 549 - - - - - -
Down regulated (> 1.3-fold) - 20 109 115 277 81 8
Up regulated (> 1.3-fold) - 18 32 58 62 33 8
Challenge Infection
Unique ESTs Comparisona
PI_C1 PI_C2 PI_C3 C1_C2 C1_C3 C2_C3
ESTs with RefSeq 1066 285 430 498 152 192 309
Modulated more than 1.3-fold (up or down) 373 - - - - - -
Down regulated (> 1.3-fold) - 55 105 122 23 23 47
Up regulated (> 1.3-fold) - 32 42 54 14 16 32
a Comparisons are described in Methods.
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signalling, P = 1.02 × 10-3) presented in Additional file 2
had the lowest significance levels, an indication of the
association between the pathway and the data set. The
expression of genes associated with these pathways
tended to be modulated to the greatest degree between
the first week of the first Immunising infection (I1) and
the first week of the second Immunising infection (I2).
The decrease in gene expression in early steps of the
acute phase response is consistent with the down-regu-
lation of genes encoding TRAF6, TCF4 and STAT3, and
up-regulation of HNRNPK. Modulation of transcript
levels of genes encoding the acute phase response pro-
teins FGG, HPX, C4, CRP and A2M (decrease) and RBP
(increase) also support down-regulation of this response.
Contrary to this, was the decrease in ALB, AMBP,
APOH, ITIH2 and increase in ITIH4, FTL and LBP
transcript levels.
Genes encoding proteins involved in Caveolar-mediated
Endocytosis, such as the integrins (ITGA3, ITGB1,
ITGA9, ITGAV), the protein kinase, FYN, the regulatory
GTPase RAB5C, beta-2-microglobin (B2M), CD48 and
albumin (ALB) were all down-regulated, suggesting a
down-regulation of this pathway. In contrast, the levels of
DMN2 encoding the GTPase dynamin 2 and ACTG2
encoding actin increased. The genes encoding major histo-
compatability Class II proteins (HLA-DMB, HLA-DRA,
HLA-DRB1, HLA-DMA) responsible for MHC Class II
antigen presentation were down-regulated as were the
genes expressing TAP2, a transporter protein and PSEM2
a component of the immunoproteosome involved in pre-
sentation of antigen by major histocompatability complex
Class I suggesting Antigen Presentation via both the Class
I and Class II pathways was affected during repeated trun-
cated immunising infections. Further, a number of genes
encoding ubiquitin-proteosome system components
responsible for targeting, via conjugation of multiple ubi-
quitin units, of proteins for degradation by the proteosome
were modulated during the development of immunity.
The expression of genes encoding the ubiquitinating
enzymes, UBE2D2 and UBE4A decreased while that of
UBE2J1 increased. Of the genes encoding proteins
involved in degradation; PSMD5 and USP15 were
decreased while USP10 and USP4 increased. Transcription
of genes encoding the heat shock proteins, HSPA5,
HSPA8, and HSP90AA1 was consistently reduced. The
major histocompatability proteins, beta-2-microglobin
(B2M) and the low affinity IgE receptor (FCER2 or CD23),
all associated with IL-4 signalling, were down-regulated
while the ribosomal S6 kinase (RPS6KB2) was up-regu-
lated in this data set.
Modulation of gene expression during challenge infection
Of the ESTs significantly regulated during the
challenge infection, 121 ovine ESTs mapping to 113
different Human or Bovine Reference genes were
linked to immune functions (Additional file 3), inclu-
sive of genes associated with the inflammatory
response, immune cell trafficking, inflammatory dis-
ease, antigen presentation, humoral immune response,
cell-mediated immune response, lymphoid tissue struc-
ture, infection mechanism, immunological disease and
apoptosis of eukaryotic cells (P values < 0.02, Ingenuity
Pathways Analysis Functional groupings). The major
trend during challenge was for a down-regulation in
the expression of these immune-associated genes, but
the degree of down-regulation was not as extensive
when compared to the immunising infections (Addi-
tional files 1 and 3). The most consistently up-regu-
lated immune gene was selenoprotein S (SELS, 3/6
comparisons). Expression increased 1.54-fold in the
first week of the Challenge infection, compared to the
Pre-infection, and 1.75-fold in the third week after
Challenge infection, compared to the Pre-infection
sample. This gene was not significantly modulated in
the immunising infection data set. TNF receptor asso-
ciated factor 5 (TRAF5) had the most consistently (3/6
comparisons) down regulated transcript levels. Levels
decreased 2.4-fold in the first week of the Challenge
infection, compared to the Pre-infection, and 3.4-fold
after the third week, compared to the Pre-infection
sample (Additional file 3). Over all, the most substan-
tial fold-change for all genes modulated during the
challenge infection tended to occur when the first
week of the Challenge infection (C1) was compared to
the Pre-infection (PI) sample pool.
The most significant canonical pathways associated
with this data set were Acute Phase Response Signalling
(P = 4.46 × 10-8), Complement Signalling (P = 4.5 × 10-
3) and IL-4 Signalling (P = 1.22 × 10-2). During the chal-
lenge infection 10% of genes encoding proteins involved
in the acute phase response were modulated (Additional
file 4). Consistent with a decreased acute phase response
were the down-regulation of STAT3 and RIPK1, up-
regulation of HNRNPK and the modulation of acute
phase response proteins C9, ITIH3, HPX, HP and ALB
ESTs. Inconsistent with the decreased acute phase
response was the observed increase in the expression of
TCF4, encoding transcription factor 4, and the down-
regulation of acute phase response proteins AMBP, TF,
ITIH2 and AHSG. A number of the key components of
the complement system (C1QC, C3, C9, C7) were
down-regulated during the challenge infection. The
interleukin 4 receptor (IL4R) was consistently up-
regulated when either Challenge infection 1 or 2 pools
were compared to the Pre-infection pool. Major histo-
compatability proteins (HLA-DMA, HLA-DQB1, B2M)
and the low affinity IgE receptor (FCER2 or CD23), end
products of IL4 signalling, were all down-regulated.
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Discussion
We deliberately interrogated a large set of ESTs derived
primarily from DCs on the arrays in order to maximise
our understanding of immune gene expression in a nat-
ural cell pool which is highly enriched for DC. These
cells migrate out of the intestinal mucosa which forms
the inter-face between host and nematode, into mesen-
teric lymph nodes, where immunological responses are
initiated. This study describes global gene expression
profiles of afferent lymph cells during the development
of immunity to a gastrointestinal parasite. This under-
standing is crucial for the development of immune mod-
ulatory treatments, as well as for new treatment such as
vaccines to control parasite infections.
For this data we employed a pooling strategy of indivi-
dual samples. Analysis of cytokine gene expression in
these pools by qRT-PCR revealed the expected over-
expression of Th2-type cytokines. This is evidence that
the more persistent modulations of gene expression are
not obscured by this pooling strategy.
Due to the difficult nature of experiments involving
collection of lymph for 13 weeks, not all the animals
were patent for the entire term of the experiment.
Therefore we cannot exclude some degree of bias at the
late stages of the experiment.
It is well established that many helminths are able to
produce a whole range of bioactive molecules that mod-
ulate the immune response of a host [17]. Of these
molecules, glycans have been shown to be key players in
inducing Th2-type and anti-inflammatory responses
[18-20]. Our data not only showed a down-regulation of
many individual genes involved in immunity but also
are indicative of a down-regulation of entire immunolo-
gical pathways, although it remains to be determined
what aspects of the changes in gene expression are due
to the natural response of the host to GIN infection.
These data are consistent with in vitro studies of hel-
minth-stimulated monocyte-derived dendritic cells
(MoDC) in which gene expression profiles are also indi-
cative of non-responsiveness [21,22]. This may be due
to the production of immunomodulatory molecules by
the parasite effectively inducing an anti-inflammatory
environment sympathetic to parasite persistence [23].
Soluble molecules from the eggs of the helminth Schis-
tosoma mansoni (SEA) by themselves have a minimal
effect on MoDC but are capable of suppressing the
expression of pro-inflammatory genes usually present
after LPS stimulation. It is hypothesised that suppression
of LPS activation may in part be due to increased pro-
duction of IL-10, an anti-inflammatory cytokine [22,24].
In general, stimulation of MoDC with helminth derived
products inhibit or partly inhibit DC maturation
assessed by measurement of DC maturation markers
such as CD86, CD40, OX40L, CD80 and MHC Class II
molecules [24-28]. Our data clearly show that under
in vivo conditions the antigen presentation pathway is
also significantly down-regulated during repeated trun-
cated immunising infections, but not during challenge
of immune lambs. It remains to be determined if inhibi-
tion of DC maturation also occurs during natural infec-
tion with gastrointestinal nematode parasites, as seen in
in vitro experiments. The predominant Th1-type
response of MoDC stimulated by bacterial lipopolysac-
caride (LPS), marked by increased chemokine produc-
tion [29] as well as expression of genes encoding
proteins related to cell structure, antigen presentation
and IFN-inducible proteins [30], was not detected at any
stage, in lambs repeatedly infected and then challenged
with intestinal nematodes.
Previous studies in sheep analysing changes in global
transcript levels associated with parasite resistance or
infection have involved analysis of abomasal, intestinal
and associated immune tissues. In this study transcript
levels have been assessed in immune cells that migrate
directly out of the tissue which harbours an intestinal
nematode parasite. Microarray analysis of gene expres-
sion profiles in both abomasal tissue and lymph nodes
has previously been used to investigate Haemonchus
contortus resistance in two different sheep breeds and
suggest that the more resistant breed has greater expres-
sion of genes associated with the inflammatory response,
gut motility, and cell differentiation and proliferation
[13]. The comparisons of gene expression in intestinal
tissue and associated immune tissues from sheep lines
genetically resistant or susceptible to GIN (H. contortus,
T. colubriformis) [8,10,11], or by the sequential biopsy of
abomasal mucosa during H. contortus infection [15] sug-
gest that genes involved in acquired immunity, oxidative
stress, apoptosis and mucosal function are modulated.
In these studies modulation of expression of ITGB1,
THBS1 and GPX1 was found to be in common with
this study. The production of oxidants by the host, are
thought to be anti-parasitic [31] and as such there is
also a requirement for antioxidants. The levels of the
antioxidant glutathione are thought to fluctuate during
GIN infections [32]. A previous study [10] and this
study have found that transcription of glutathione per-
oxidise (GPX1) increases during GIN infection, thus
supporting an increase in antioxidant activities. Keane
et al [9] found the most highly expressed genes in intest-
inal tissue of susceptible animals to be those involved in
protein degradation including a ubiquitin-like protein.
Ingenuity Pathway Analysis of data presented in this
study is indicative of a down-regulation of many genes
involved in protein ubiquitination, caveolar-mediated
endocytosis, both MHC Class I and Class II antigen pre-
sentation during immunising infections, which together
could contribute to the natural slow development of
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protective host immunity to gastrointestinal nematode
parasites. Protein ubiquitination is not only associated
with the degradation of damaged proteins but in the
regulation of cellular processes including immune
responses such as antigen presentation and activation of
pro-inflammatory responses via the transcription factor
NF-B (reviewed in [33]). Intriguingly, the heat shock
proteins encoded by HSP90AA1 and HSPA5 enhance
DC maturation. The former has also been shown to
enhance the TLR-mediated production of pro-inflamma-
tory cytokines [34,35]. In this study, the transcription of
both the HSP90AA1 and HSPA5 genes was down-
regulated during repeated immunising infections sugges-
tive of an inhibition of DC maturation. Suppression of
DC maturation is well known from in vitro studies in
which helminth products have been shown to regulate
DC cytokine and cell surface molecule maturation mar-
kers [24,25,28]. It remains to be established whether or
not heat shock proteins HSP90AA1 and HSPA5 are
involved.
A number of genes encoding proteins involved in
acute phase responses were also modulated in this data
set. Acute phase proteins (APPs) are predominantly
synthesised in the liver. However, their levels can also
be modulated in non-hepatic tissues such as the lymph
node [36,37] and possibly in migrating lymph cells. The
expression of genes encoding a group of APPs were
down-regulated, consistent with routine function during
the acute phase response. One of the most highly down-
regulated genes during the development of immunity
was hemopexin (HPX). The signalling adaptor molecule
TRAF6 and the transcription factor STAT3, both
involved in elicitation of an acute phase response, were
down-regulated while HNHKPK, a negative regulator of
the response was up-regulated. The regulation of these
genes was observed during both the development of
immunity and the challenge infection. Modulation of
these genes is consistent with a down-regulation of the
acute phase response.
Signalling is an essential process required for the inte-
gration of immune responses. A number of proteins
involved in such pathways were significantly modulated
during the development of immunity to parasite infec-
tion. TRAF proteins function as adaptor proteins in
TNF signalling pathways and may play a role in immu-
nity to gastrointestinal parasites [38]. TRAF5 transcript
levels where the most significantly and consistently
modulated during repeated immunising infections and
remained low during the challenge infection. TRAF5 sig-
nalling is involved in the development of Th2-type
responses, as exemplified by knockout mice studies in
which TRAF5-/- mice showed an enhanced Th2 pheno-
type [39]. Our data clearly show the development of
Th2-type effector cytokine response during repeated
immunising infections which is supported by the strong
down-regulation of TRAF5 signalling and the up-regula-
tion of the IL-18 binding protein. Interleukin-18 binding
protein (IL-18BP) binds and inhibits the biological activ-
ity of the pro-inflammatory Th1-response promoting
cytokine IL-18 [40]. IL-18 has also been implicated in
the susceptibility of mice to Trichuris muris infection
which is achieved via down-regulation of the production
of IL-13 [41]. The genes IL22RA1, IL20RA, IL10RB and
IL10RA, encode receptors for members of the IL-10
cytokine family (IL-10, IL-20, IL-22, IL-26). IL10RB
associates with IL22RA1 or with IL20RA to form
respectively the IL-22 or the IL-26 receptor while
IL20RA and IL20RB form the IL-20 receptor. The tran-
scription of IL10RB, IL22RA1 and IL20RA were down-
regulated during the development of immunity to T.
colubriformis. Both IL-22 and IL-26 have been shown to
promote pro-inflammatory gene expression in intestinal
epithelial cells [42,43]. Recently the removal of IL-22
was shown to have a protective effect in gut infected
with the parasitic protozoan Toxoplasma gondii [44]. It
is feasible that these cytokines could also be involved in
the development of immunity to T. colubriformis. IL-22,
IL-20, IL-26 and IL-18 have all been implicated in
inflammatory conditions such as Crohn’s disease and
Psoriasis in humans [42,43,45,46]. IL-4, a Th2 cytokine,
plays a critical role in the host’s defence against gastro-
intestinal parasites [47]. Our data show an up-regulation
of the IL-4 receptor (IL4R) during the challenge infec-
tion indicative of a Th2-type response. Other genes
such as those encoding major histocompatability pro-
teins, the low affinity receptor for IgE (FCER2 or CD23)
and beta-2-microgobulin (B2M) were down-regulated.
These genes are associated with, but are not exclusive
to, IL-4 signalling.
Under stress conditions, endoplasmic reticular function
is impaired resulting in activation of the transcription fac-
tor NF-B and the expression of pro-inflammatory cyto-
kines. Maintenance of endoplasmic reticular integrity
under such conditions can involve selenoprotein S (SELS).
A genetic variant of the SELS gene with impaired expres-
sion and suppression of transcript levels with a SELS small
interfering RNA suggests that a decrease in SELS expres-
sion is linked to an increase in pro-inflammatory cytokine
levels [48]. Any elevation in SELS transcript levels during
immunising infections and during parasite challenge is
therefore consistent with the ability of parasites to induce
the suppression of an inflammatory response. Cysteine
dioxygenase (CDO1) may be involved in the inflammatory
response to oxidative stress via the regulation of taurine
metabolism. Regulation of this involvement is however
thought to be via a post-translational mechanism [49] and
so further investigation would be required to determine
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the significance of the modulation of this gene during the
development of immunity to gastrointestinal parasites.
Conclusions
Our findings present a global picture of the changes in
gene expression in cells trafficking in afferent lymph
over extended periods of time during the development
of immunity and challenge with the gastrointestinal
parasite T. colubriformis. This report describes gene
expression profiles in immune cells draining directly
from the intestinal mucosa; the interface between the
host and the nematode. Data are suggestive of a down-
regulation of the expression of immune genes, a down-
regulation that may be relevant to the development of
immunity. These results lay the groundwork for further
studies on nematode mediated immune-modulation
which results in this slow development of immunity to
gastrointestinal parasites. In particular, it remains to be
determined if the observed changes in gene expression
are also seen on a protein level resulting in functional
changes of pathways.
Methods
Animals and experimental design
All animal experiments and surgical procedures were
approved by the Animal Ethics Committee of the Walla-
ceville Animal Research Centre. Animals were raised
nematode free and were fed on a standardised diet con-
sisting of sheep nuts and Lucerne chaff. Five outbred
nematode naïve female Romney lambs were surgically
fitted with lymphatic cannulae to enable continuous col-
lection of afferent lymph for up to 13 weeks [16]. Lambs
were immunized by orally infecting them with 50,000 T.
colubriformis L3 larvae and the infection was terminated
with oxfendazole (5 mg/kg; Systamex® COOPERS) 2
weeks later. After a resting period of one week, the oral
infection followed by drenching procedure (= ‘truncated-
immunising infection’) was repeated twice. A final drench
was given at week 9 and sheep were then challenged with
50,000 T. colubriformis a week later. The challenge infec-
tion was allowed to develop for 3 weeks. Faecal egg
counts (FEC) of zero, determined at week 13, demon-
strated the development of protective immunity. This
regime of truncated-immunising infections and challenge
infection is shown diagrammatically in Figure 3A.
Sampling of lymph
Lymph was collected continuously into sterile flasks
containing heparin (Sigma-Aldrich, St Louis, MO) and
antibiotics (penicillin and streptomycin; Sigma). In addi-
tion, up to four samples of 5 to 10 ml of fresh lymph
were collected under aseptic conditions over a period of
15 to 30 min daily, into sample tubes containing heparin
to allow sampling of cells for RNA extraction. Cells
(approximately 108) were promptly separated from
lymph plasma by centrifugation at 400 g for 3 min,
washed once in cold PBS and re-suspended in RNAlater
(Ambion, Austin, TX) to preserve integrity. Samples
were stored at -20°C until subjected to RNA extraction.
Parasitology
Infective T. colubriformis larvae were cultured under
standard procedures from eggs obtained from faeces of
a mono-specifically infected sheep. Faecal egg counts
were performed on each animal at weekly intervals
throughout the duration of the experiment using the
modified McMaster method [50].
Microarray preparation
Ovine cDNA libraries were generated and single pass
sequenced to generate expressed sequence tags (ESTs).
The amplification of cDNAs and array preparation were
as described previously [8]. An ovine microarray con-
taining 10,458 amplified cDNAs and 119 control spots
was used. The majority (5215) of cDNAs printed on the
array were derived from immune tissue libraries, includ-
ing isolated dendritic cells (5053) with the remaining
162 from lymph node tissue, Peyers Patches and muco-
sal lymphoid tissue. The other cDNAs printed onto the
array were from gall bladder (2638), liver (1748), foetal
and reproductive tissue (734), wool follicles (96) and
skin cells (30).
RNA isolation, fluorescent labelling and slide
hybridisation
Total RNA was isolated from individual lymph cell sam-
ples using Trizol (Invitrogen, Carlsbad, CA) and the
appropriate RNA samples pooled and further purified
using an RNeasy kit (Qiagen, Hilden, Germany). RNA
concentrations were determined by the spectrophoto-
metric measurement of absorption at 260 nm and every
RNA preparation was assessed for integrity and the
absence of genomic DNA contamination by agarose gel
electrophoresis. First strand cDNA labelled with either
Cy3 or Cy5 (Amersham Biosciences, Uppsala, Sweden)
was produced from 20 μg of total pooled RNA using the
SuperScript Indirect cDNA Labeling System (Invitro-
gen). All procedures were as described by the manufac-
turer. Cy3 and Cy5-labelled cDNA were pooled,
concentrated to 10 μl by ethanol precipitation prior to
denaturation at 95°C, combining with SlideHyb glass
array hybridisation buffer #1 (60 ul, Ambion) and
applied to the array. Array pre-hybridisation and hybri-
disation conditions, scanning and image processing were
as described [8], except that hybridisation was at 52°C.
Pools (PI, Pre-infection, week 0; I1, Immunising infec-
tion 1, week 1; I2, Immunising infection 2, week 4; I3,
Immunising infection 3, week 7; C1, first week after
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Challenge infection, week 10; C2, second week after
Challenge infection, week 11; C3, third week after Chal-
lenge infection, week 12; Figure 3A) consisted of equal
amounts of total RNA from each animal and for each
day over a period of 7 days being pooled. Each pool was
compared with every other pool (Figure 3B). In total 12
slides were hybridised to investigate the development of
immunity (Immunising infections) and another 12 to
investigate the challenge of immunised sheep (Challenge
infection), and included slides where first strand cDNA
was labelled with the opposite dye (dye swap). The
number of animals contributing to each pool changed as
not all animals had a patent cannula for the entire
experimental period of 13 weeks (Figure 3A).
Microarray normalisation and analysis
Data for individual slides were normalised as described
previously [8,51]. ESTs with either a normalised mean
log intensity < 9 and with > 6 bad (unreadable) spots
out of 12 were excluded from further analysis. The stan-
dardized residual of the normalized log ratio of the
mean (SR_mean) was calculated for each EST and con-
verted to a fold change. An EST was included for









































































Figure 3 Experimental Design. (A) Truncated Immunising infection and Challenge protocol. Daily afferent lymph samples were collected over a
13 week period. RNA was pooled (sample pools) after extraction from afferent lymph samples from weeks labelled PI (Pre-infection, week 0), I1
(Immunising infection 1, week 1), I2 (Immunising infection 2, week 4), I3 (Immunising infection 3, week 7), C1 (Challenge infection, week 10), C2
(Challenge infection, week 11) and C3 (Challenge infection, week 12). N; number of animals in each sample pool, solid arrows show infection
with 50,000 T. colubriformis (Tc) and dashed arrows show drench treatment. (B) Hybridisation of RNA pools. Solid lines show the comparisons
made; solid arrows show nematode infection and dashed arrows show drench treatments.
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comparisons the change was greater than 1.3 (up or
down) and the P value for this change was < 0.05. The
modulation threshold of 1.3-fold was slightly more strin-
gent than that validated and used by others [52]. A
Human or Bovine Reference Sequence (ftp://ftp.ncbi.nih.
gov/refseq/) corresponding to each EST was determined
by BLAST. Those with E values less than 1 × 10-19 were
included. Canonical pathways and Functional groupings
were generated through the use of Ingenuity Pathways
Analysis (Ingenuity Systems, http://www.ingenuity.com).
All the microarray data presented in this publication have
been deposited in NCBI ‘s Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) under accession num-
ber GSE23859 for the Immunising infection data set and
GSE23863 for the Challenge infection data set.
Quantitative real-time PCR
First-strand cDNA was synthesised from the same
RNA samples used in the microarray experiments.
Synthesis of cDNA and the procedure used to quanti-
tatively assess gene expression using quantitative real-
time PCR (qRT-PCR) was done as described previously
[5]. Oligonucleotides (Table 2) designed to amplify the
ovine homologue of the src-like adaptor (SLA), chemo-
kine (C-X-C) receptor 3 (CXCR3), TNF receptor-asso-
ciated factor 3 (TRAF3), toll-like receptor 6 (TLR6),
granulysin (GNLY), predicted WD repeat domain 73
(LOC509457) and a novel (no Reference Sequence)
ovine EST (Novel Gene) were based on their EST
sequences. Prior to qRT-PCR the identity of the EST
spotted onto the array was confirmed by partial
sequence analysis. Quantification of IL-5, IL-13, IL-4
and IFNg levels within the same RNA samples were
assessed as described previously [16].
Additional material
Additional file 1: Changes in immune gene expression during the
Immunising infections are tabulated. The data set is described:
a Genes associated with Immune Function in the Ingenuity Pathways
Knowledge Base where at least one comparison has a P value < 0.05
(shown in bold type). Differential expression of genes in pooled samples
PI_I1, PI_I2, PI_I3, I1_I2, I1_I3, I2_I3 where treated as described in
Methods. Down-regulated genes with more than a 1.3-fold decrease
(-1.3) and a P value < 0.05 are highlighted green. Up-regulated genes
with > 1.3-fold increase and a P value < 0.05 are highlighted red. Genes
where the change is less than a 1.3-fold decrease or increase and with a
P value < 0.05 are highlighted grey.
Additional file 2: The modulation of canonical pathways during
Immunising infections is tabulated. The data set is described:
a Significance level. b Proportion of pathway associated genes. c Genes
associated with Canonical Pathways in the Ingenuity Pathways
Knowledge Base where at least one comparison has a P value < 0.05
(shown in bold type). Differential expression of genes in pooled samples
PI_I1, PI_I2, PI_I3, I1_I2, I1_I3, I2_I3 are shown. Down-regulated genes
with more than a 1.3-fold decrease (-1.3) and a P value < 0.05 are
highlighted green. Up-regulated genes with > 1.3-fold increase and a P
value < 0.05 are highlighted red. Genes where the change is less than a
1.3-fold decrease or increase and with a P value < 0.05 are highlighted
grey.
Additional file 3: Changes in immune gene expression during the
Challenge infection are tabulated. The data set is described: a Genes
associated with Immune Function in the Ingenuity Pathways Knowledge
Base where at least one comparison has a P value < 0.05 (shown in bold
type). Differential expression of genes in pooled samples PI_C1, PI_C2,
PI_C3, C1_C2, C1_C3, C2_C3 are shown. Down-regulated genes with
more than a 1.3-fold decrease (-1.3) and a P value < 0.05 are highlighted
green. Up-regulated genes with > 1.3-fold increase and a P value < 0.05
are highlighted red. Genes where the change is less than a 1.3-fold
decrease or increase and with a P value < 0.05 are highlighted grey.
Additional file 4: The modulation of canonical pathways during
Challenge is tabulated. The data set is described: a Significance level.
b Proportion of pathway associated genes. c Genes associated with
Canonical Pathways in the Ingenuity Pathways Knowledge Base where at
least one comparison has a P value < 0.05 (shown in bold type).
Differential expression of genes in pooled samples PI_I1, PI_I2, PI_I3,
I1_I2, I1_I3, I2_I3 are shown. Down-regulated genes with more than a
1.3-fold decrease (-1.3) and a P value < 0.05 are highlighted green. Up-
regulated genes with > 1.3-fold increase and a P value < 0.05 are
highlighted red. Genes where the change is less than a 1.3-fold decrease
or increase and with a P value < 0.05 are highlighted grey.
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a Primers were designed to the ovine homologues of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), the src-like adaptor (SLA), chemokine (C-
X-C) receptor 3 (CXCR3), TNF receptor-associated factor 3 (TRAF3), toll-like
receptor 6 (TLR6), granulysin (GNLY), predicted WD repeat domain 73
(LOC509457) and a novel ovine EST (Novel Gene).
Knight et al. BMC Immunology 2010, 11:51
http://www.biomedcentral.com/1471-2172/11/51
Page 10 of 12
Received: 17 June 2010 Accepted: 17 October 2010
Published: 17 October 2010
References
1. Kaminsky R: Drug resistance in nematodes: a paper tiger or a real
problem? Current Opinion in Infectious Diseases 2003, 16(6):559-564.
2. Besier B: New anthelmintics for livestock: the time is right. Trends in
Parasitology 2007, 23(1):21-24.
3. Emery DL, McClure SJ, Wagland BM, Jones WO: Studies of stage-specific
immunity against Trichostrongylus colubriformis in sheep: immunization
by normal and truncated infections. International Journal for Parasitology
1992, 22(2):215-220.
4. Stankiewicz M, Cabaj W, Pernthaner A, Hadas E: Immunisation of sheep by
drug-abbreviated infections of Ostertagia circumcincta and
Trichostrongylus colubriformis against field challenge of gastro-intestinal
nematodes. Veterinary Parasitology 1996, 67(1-2):121-132.
5. Pernthaner A, Cole SA, Morrison L, Hein WR: Increased expression of
interleukin-5 (IL-5), IL-13, and tumor necrosis factor alpha genes in
intestinal lymph cells of sheep selected for enhanced resistance to
nematodes during infection with Trichostrongylus colubriformis. Infection
& Immunity 2005, 73(4):2175-2183.
6. Gasbarre LC: Effects of gastrointestinal nematode infection on the
ruminant immune system. Vet Parasitol 1997, 72(3-4):327-337, discussion
337-343.
7. Almeria S, Canals A, Gomez-Munoz MT, Zarlenga DS, Gasbarre LC:
Characterization of protective immune responses in local lymphoid
tissues after drug-attenuated infections with Ostertagia ostertagi in
calves. Vet Parasitol 1998, 80(1):53-64.
8. Diez-Tascon C, Keane OM, Wilson T, Zadissa A, Hyndman DL, Baird DB,
McEwan JC, Crawford AM: Microarray analysis of selection lines from
outbred populations to identify genes involved with nematode parasite
resistance in sheep. Physiological Genomics 2005, 21(1):59-69.
9. Keane OM, Zadissa A, Wilson T, Hyndman DL, Greer GJ, Baird DB,
McCulloch AF, Crawford AM, McEwan JC: Gene expression profiling of
naive sheep genetically resistant and susceptible to gastrointestinal
nematodes. BMC Genomics 2006, 7:42.
10. Menzies M, Reverter A, Andronicos N, Hunt P, Windon R, Ingham A:
Nematode challenge induces differential expression of oxidant,
antioxidant and mucous genes down the longitudinal axis of the sheep
gut. Parasite Immunology 2010, 32(1):36-46.
11. Andronicos N, Hunt P, Windon R: Expression of genes in gastrointestinal
and lymphatic tissues during parasite infection in sheep genetically
resistant or susceptible to Trichostrongylus colubriformis and
Haemonchus contortus. International Journal for Parasitology 2010,
40(4):417-429.
12. Ingham A, Reverter A, Windon R, Hunt P, Menzies M: Gastrointestinal
nematode challenge induces some conserved gene expression changes
in the gut mucosa of genetically resistant sheep. International Journal for
Parasitology 2008, 38(3-4):431-442.
13. MacKinnon KM, Burton JL, Zajac AM, Notter DR: Microarray analysis reveals
difference in gene expression profiles of hair and wool sheep infected
with Haemonchus contortus. Veterinary Immunology & Immunopathology
2009, 130(3-4):210-220.
14. Rowe A, Gondro C, Emery D, Sangster N: Genomic analyses of
Haemonchus contortus infection in sheep: Abomasal fistulation and two
Haemonchus strains do not substantially confound host gene
expression in microarrays. Veterinary Parasitology 2008, 154(1-2):71-81.
15. Rowe A, Gondro C, Emery D, Sangster N: Sequential microarray to identify
timing of molecular responses to Haemonchus contortus infection in
sheep. Veterinary Parasitology 2009, 161(1-2):76-87.
16. Hein WR, Barber T, Cole SA, Morrison L, Pernthaner A: Long-term collection
and characterization of afferent lymph from the ovine small intestine.
Journal of Immunological Methods 2004, 293(1-2):153-168.
17. Johnston MJ, MacDonald JA, McKay DM: Parasitic helminths: a
pharmacopeia of anti-inflammatory molecules. Parasitology 2009,
136(2):125-147.
18. Atochina O, Harn D: Prevention of psoriasis-like lesions development in
fsn/fsn mice by helminth glycans. Experimental Dermatology 2006,
15(6):461-468.
19. Harn DA, McDonald J, Atochina O, Da’dara AA: Modulation of host
immune responses by helminth glycans. Immunological Reviews 2009,
230(1):247-257.
20. Terrazas CA, Gomez-Garcia L, Terrazas LI: Impaired pro-inflammatory
cytokine production and increased Th2-biasing ability of dendritic cells
exposed to Taenia excreted/secreted antigens: A critical role for
carbohydrates but not for STAT6 signaling. International Journal for
Parasitology 2010, 40(9):1051-1062.
21. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB:
Unique gene expression profiles of human macrophages and dendritic
cells to phylogenetically distinct parasites. Blood 2003, 102(2):672-681.
22. Kane CM, Cervi L, Sun J, McKee AS, Masek KS, Shapira S, Hunter CA,
Pearce EJ: Helminth antigens modulate TLR-initiated dendritic cell
activation. Journal of Immunology 2004, 173(12):7454-7461.
23. Soares MF, Araujo CA: Helminth products as a potential therapeutic
strategy for inflammatory diseases. Inflammation & Allergy Drug Targets
2008, 7(2):113-118.
24. Rigano R, Buttari B, Profumo E, Ortona E, Delunardo F, Margutti P, Mattei V,
Teggi A, Sorice M, Siracusano A: Echinococcus granulosus antigen B
impairs human dendritic cell differentiation and polarizes immature
dendritic cell maturation towards a Th2 cell response. Infection &
Immunity 2007, 75(4):1667-1678.
25. Cervi L, MacDonald AS, Kane C, Dzierszinski F, Pearce EJ: Cutting edge:
dendritic cells copulsed with microbial and helminth antigens undergo
modified maturation, segregate the antigens to distinct intracellular
compartments, and concurrently induce microbe-specific Th1 and
helminth-specific Th2 responses. Journal of Immunology 2004,
172(4):2016-2020.
26. Balic A, Harcus Y: Selective maturation of dendritic cells by
Nippostrongylus brasiliensis-secreted proteins drives Th2 immune
responses. European Journal of Immunology 2004, 34(11):3047-3059.
27. Jenkins SJ, Mountford AP: Dendritic cells activated with products released
by schistosome larvae drive Th2-type immune responses, which can be
inhibited by manipulation of CD40 costimulation. Infection & Immunity
2005, 73(1):395-402.
28. Langelaar M, Aranzamendi C, Franssen F, Van der Giessen J, Rutten V, Van
der Ley P, Pinelli E: Suppression of dendritic cell maturation by Trichinella
spiralis excretory/secretory products. Parasite Immunology 2009,
31(10):641-645.
29. Messmer D, Messmer B, Chiorazzi N: The global transcriptional maturation
program and stimuli-specific gene expression profiles of human myeloid
dendritic cells. International Immunology 2003, 15(4):491-503.
30. Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K:
Identification of genes specifically expressed in human activated and
mature dendritic cells through serial analysis of gene expression. Blood
2000, 96(6):2206-2214.
31. Chiumiento L, Bruschi F: Enzymatic antioxidant systems in helminth
parasites. Parasitology Research 2009, 105(3):593-603.
32. Liu SM, Smith TL, Palmer DG, Karlsson LJE, Besier RB, Greeff JC: Biochemical
differences in Merino sheep selected for resistance against gastro-
intestinal nematodes and genetic and nutritional effects on faecal worm
egg output. Animal Science 2005, 81(1):149-157.
33. Ben-Neriah Y: Regulatory functions of ubiquitination in the immune
system. Nature Immunology 2002, 3(1):20-26.
34. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM: Toll-like
receptors in inflammation, infection and cancer. International
Immunopharmacology 2007, 7(10):1271-1285.
35. Kuppner MC, Gastpar R, Gelwer S, Nossner E, Ochmann O, Scharner A,
Issels RD: The role of heat shock protein (hsp70) in dendritic cell
maturation: hsp70 induces the maturation of immature dendritic cells
but reduces DC differentiation from monocyte precursors. European
Journal of Immunology 2001, 31(5):1602-1609.
36. Leak LV, Liotta LA, Krutzsch H, Jones M, Fusaroa VA, Ross SJ, Zhao Y,
Petricoin EF III: Proteomic analysis of lymph. Proteomics 2004, 4(3):753-765.
37. Skovgaard K, Mortensen S, Boye M, Poulsen KT, Campbell FM, Eckersall PD,
Heegaard PM: Rapid and widely disseminated acute phase protein
response after experimental bacterial infection of pigs. Veterinary
Research 2009, 40(3):23.
38. Wajant H, Henkler F, Scheurich P: The TNF-receptor-associated factor
family: Scaffold molecules for cytokine receptors, kinases and their
regulators. Cellular Signalling 2001, 13(6):389-400.
Knight et al. BMC Immunology 2010, 11:51
http://www.biomedcentral.com/1471-2172/11/51
Page 11 of 12
39. So T, Salek-Ardakani S, Nakano H, Ware CF, Croft M: TNF receptor-
associated factor 5 limits the induction of Th2 immune responses.
Journal of Immunology 2004, 172(7):4292-4297.
40. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M:
Interleukin-18 binding protein: a novel modulator of the Th1 cytokine
response. Immunity 1999, 10(1):127-136.
41. Helmby H, Takeda K, Akira S, Grencis RK: Interleukin (IL)-18 promotes the
development of chronic gastrointestinal helminth infection by
downregulating IL-13. Journal of Experimental Medicine 2001,
194(3):355-364.
42. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H,
Marquardt A, Jagla W, Popp A, et al: IL-22 is increased in active Crohn’s
disease and promotes proinflammatory gene expression and intestinal
epithelial cell migration. American Journal of Physiology - Gastrointestinal &
Liver Physiology 2006, 290(4):G827-838.
43. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Goke B, Diepolder HM,
Auernhammer CJ, Brand S: The role of the novel Th17 cytokine IL-26 in
intestinal inflammation. Gut 2009, 58(9):1207-1217.
44. Wilson MS, Feng CG, Barber DL, Yarovinsky F, Cheever AW, Sher A, Grigg M,
Collins M, Fouser L, Wynn TA: Redundant and pathogenic roles for IL-22
in mycobacterial, protozoan, and helminth infections. Journal of
Immunology 2010, 184(8):4378-4390.
45. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, Luzza F,
Fusco A, Pallone F: Bioactive IL-18 expression is up-regulated in Crohn’s
disease. Journal of Immunology 1999, 163(1):143-147.
46. Wolk K, Witte E, Warszawska K, Schulze-Tanzil G, Witte K, Philipp S, Kunz S,
Docke WD, Asadullah K, Volk HD, et al: The Th17 cytokine IL-22 induces
IL-20 production in keratinocytes: a novel immunological cascade with
potential relevance in psoriasis. European Journal of Immunology 2009,
39(12):3570-3581.
47. Finkelman FD, Shea-Donohue T, Morris SC, Gildea L, Strait R, Madden KB,
Schopf L, Urban JF Jr: Interleukin-4- and interleukin-13-mediated host
protection against intestinal nematode parasites. Immunol Rev 2004,
201:139-155.
48. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Abel
Azim DM, Cai G, Mahaney MC, Comuzzie AG, et al: Genetic variation in
selenoprotein S influences inflammatory response. Nature Genetics 2005,
37(11):1234-1241.
49. Schuller-Levis GB, Park E: Taurine and its chloramine: modulators of
immunity. Neurochemical Research 2004, 29(1):117-126.
50. Whitlock HV: Some modifications of the McMaster helminth egg-
counting techniques and apparatus. Journal of the Council of Scientific and
Industrial Research 1948, 21:177-180.
51. Baird D, Johnstone P, Wilson T: Normalization of microarray data using a
spatial mixed model analysis which includes splines. Bioinformatics 2004,
20(17):3196-3205.
52. Araujo RN, Padilha T, Zarlenga D, Sonstegard T, Connor EE, Van Tassel C,
Lima WS, Nascimento E, Gasbarre LC: Use of a candidate gene array to
delineate gene expression patterns in cattle selected for resistance or
susceptibility to intestinal nematodes. Veterinary Parasitology 2009, 162(1-
2):106-115.
doi:10.1186/1471-2172-11-51
Cite this article as: Knight et al.: The gastrointestinal nematode
Trichostrongylus colubriformis down-regulates immune gene expression
in migratory cells in afferent lymph. BMC Immunology 2010 11:51.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Knight et al. BMC Immunology 2010, 11:51
http://www.biomedcentral.com/1471-2172/11/51
Page 12 of 12
